Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CSTB | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | NKX2-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | C9orf116 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | SLC2A5 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | GK5 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | METTL3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | SEMA6C | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | OR2L13 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | TGS1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | FER | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |